Negotiable Instruments Act - High Courts should issue practice directions to Magistrates to record reasons before converting trial of complaints u/s 138 of the Negotiable Instruments Act from summary trial to summons trial: SC (See 'Legal Desk') IBC - There is no collusion between Liquidator and Respondent to defeat rightful claims of ex-workers: NCLAT (See 'Legal Desk') Airlines may cut losses to Rs 10,000 cr this fiscal: CRISIL (See 'Corp Brief') Ease My Trip, Cleartrip partner with MoT to strengthen tourism (See 'Corp Brief') Limitation Act - Reflection of debt in books of accounts amounts to acknowledgment of debt u/s 18 of the Limitation Act, 1963 - SC Lager Bench (See 'Legal Desk') PMLA - Bail application can be rejected considering nature of accusations against the applicant, his conduct and non-co-operation in investigation: HC (See 'Legal Desk') IBC - CIRP is time bound process and Appellant being outsider is neither aggrieved party in process of CIRP nor has locus standi to file the appeal: NCLAT (See 'Legal Desk') Arbitration – HC can interfere with impugned award u/s 34 to the extent it is patently illegal and erroneous on face: HC (See 'Legal Desk') IBC - Right to extend date of limitation can't be availed even without Debtor's acknowledgement of one's debt: NCLAT (See 'Legal Desk') L & T appoints Anil Rander as CFO Construction arm of L&T receives multiple orders worth Rs 2,500 crore Apple makes USD 200 mn Restore Fund to reduce carbon NIXI announces 3 initiatives to boost adoption of IPv6 (See 'Corp Brief') Microsoft to promote digital agriculture in 100 Indian villages (See 'Corp Brief') Mall revenues to be lower than pre-pandemic level in FY22: CRISIL (See 'Corp Brief') Dassault Systemes Foundation to support Indian entrepreneurs (See 'Corp Brief') Companies Act, 2013 - Conditions u/s 212(6)(b) ought to be fulfilled even when fraud committed u/s 447 causes no loss to public exchequer and interest: HC (See 'Legal Desk') IBC - Appeal should be dismissed as Appellant is not serious in pursuing his remedy before NCLT: NCLAT (See 'Legal Desk') SEBI Regulations - Mere 'forwarded as received' WhatsApp message circulated on group regarding quarterly financial results of Company closely matching with vital statistics some time before the publication of same does not amount to UPSI: SAT (See 'Legal Desk') Trade Mark Act - Plaintiff is prior user and adoption of impugned mark by defendant is prima facie dishonest: HC (See 'Legal Desk') Pandemic turns into 'Kalashnikov' - A Pogrom against the Poor!

HURL receives Rs 813 crore interest-free loan for plant revival project

Published: Apr 07, 2021


NEW DELHI, APR 7, 2021: THE Chemicals and Fertilisers Ministry on Tuesday handed over a cheque of Rs. 813.24 crore as interest-free loan to State-owned Hindustan Urvarak and Rasayan Ltd (HURL) for the revival of its Gorakhpur, Sindriand Barauni projects

Minister for Chemicals and Fertilisers Mr DV Sadananda Gowda said the loan will further strengthen HURL's financial condition during COVID-19 and assist it to complete its project in time.

The Cabinet Committee on Economic Affairs (CCEA) had approved the revival of Gorakhpur and Sindri units of Fertiliser Corporation of India Ltd (FCIL) and the Barauni unit of Hindustan Fertiliser Corporation Ltd (HFCL) in 2016.

The operationalisation of the plants will reduce the import dependency on urea by 38.1 lakh tonne per annum and save foreign exchange, said the minister. The capacity of each plant would be 12.7 lakh tonne per annum.

HURL was incorporated as a Joint Venture (JV) of State-owned National Thermal Power Corporation (NTPC), Indian Oil Corporation Limited (IOCL), Coal India Limited (CIL) and FICL to revive the plants by end of 2021

The Centre approved a grant of interest-free loan to the tune of Rs. 1257.82 crore to HURL –Rs. 422.28 crore for Gorakhpur (Uttar Pradesh), Rs. 415.77 crore for Sindri (Jharkhand) and Rs. 419.77 crore for the Barauni (Bihar) project.

The Gorakhpur plant is nearing 89 per cent completion, Barauni is at 85.1 per cent and Sindri at 86.1 per cent as on February 28, 2021.